The BOLD signal and neurovascular coupling in autism  by Reynell, Clare & Harris, Julia J.
Developmental Cognitive Neuroscience 6 (2013) 72– 79
Contents lists available at ScienceDirect
Developmental Cognitive  Neuroscience
j our na l ho me  pa g e: h t tp : / /www.e lsev ier .com/ locate /dcn
The  BOLD  signal  and  neurovascular  coupling  in  autism
Clare  Reynell ∗, Julia  J.  Harris
Department of Neuroscience, Physiology and Pharmacology, University College London, Gower St, London, WC1E 6BT, UK
a  r  t i  c  l  e  i  n  f  o
Article history:
Received 5 February 2013
Received  in revised form 3 June 2013
Accepted 3 July 2013
Keywords:
BOLD fMRI
Autism
Blood ﬂow
a  b  s  t  r  a  c  t
BOLD  (blood  oxygen  level  dependent)  fMRI  (functional  magnetic  resonance  imaging)  is
commonly  used  to study  differences  in  neuronal  activity  between  human  populations.  As
the BOLD  response  is an  indirect  measure  of  neuronal  activity,  meaningful  interpretation
of  differences  in BOLD  responses  between  groups  relies  upon  a stable  relationship  exist-
ing between  neuronal  activity  and  the  BOLD  response  across  these  groups.  However,  this
relationship  can  be altered  by  changes  in  neurovascular  coupling  or energy  consumption,
which  would  lead  to problems  in  identifying  differences  in neuronal  activity.  In  this  review,
we focus  on  fMRI  studies  of  people  with  autism,  and  comparisons  that  are  made  of  theirNeurovascular coupling
Energy
Glutamate
BOLD responses  with  those  of  control  groups.  We  examine  neurophysiological  differences
in autism  that  may  alter  neurovascular  coupling  or energy  use,  discuss  recent  studies  that
have used  fMRI  to identify  differences  between  participants  with  autism  and  control  par-
ticipants,  and explore  experimental  approaches  that  could  help  attribute  between-group
differences  in  BOLD  signals  to  either  neuronal  or neurovascular  factors.© 2013 Elsevier Ltd. 
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Many important questions in neuroscience and neu-
rology concern differences in brain activity between two
or  more groups of people. Because fMRI is a powerful and
non-invasive tool to examine brain function in humans,
it  is often employed to read out neuronal activity in
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uch studies. However, for fMRI-based measures of brain
ctivity  to be reliably compared between populations, it
ust  be assumed that the relationship between neuronal
ctivity and the BOLD signal is the same in the different
roups. This relationship depends on the mechanism by
hich  active neurons alter local blood ﬂow (neurovascular
oupling) and on the oxygen use evoked by neuronal
ctivity (Attwell and Iadecola, 2002; Harris et al., 2011).
Several neurophysiological changes have been identi-
ed  in autism (as discussed below). These changes may
lter  the signalling from neurons to the vasculature and,
n  consequence, the relationship between neuronal activ-
ty  and the BOLD signal. Typically, studies using fMRI
o  compare control participants and participants with
utism attribute observed differences in the BOLD sig-
al  to altered neuronal activity, without considering the
ossibility that neurovascular coupling or oxygen con-
umption is also altered (Goldberg et al., 2011; Pfeifer
t  al., 2012; Watanabe et al., 2012). More recently, however,
esearchers have begun to acknowledge that neurovascu-
ar coupling or oxygen use changes must be experimentally
uled out before BOLD differences can be used as evi-
ence for differences of neuronal function between control
nd  autistic groups (Dinstein et al., 2012; Feczko et al.,
012).
In  this article, we start by brieﬂy reviewing the phys-
ological basis of the BOLD signal and the neurovascular
oupling mechanisms that mediate it. We  then look in
etail  at the neurophysiological changes that are known
o  occur in autism and how these changes might inﬂuence
eurovascular coupling and oxygen use, and thus the BOLD
esponse.  We  then examine the implications that altered
eurovascular coupling or oxygen use would have for fMRI
tudies.  By focusing on several representative studies cho-
en  from the literature, we highlight the interpretational
roblems that can occur when this issue is ignored. Finally,
e  explore ways in which the scientiﬁc community study-
ng  autism can address the challenge of separating out
eurovascular coupling and neuronal activity effects on the
OLD  signal experimentally, as some groups are already
eginning to do.
.  Neurovascular coupling and the BOLD signal
fMRI is regularly used to study neuronal activity in
umans because of its non-invasive nature, which allows
t  to be used to study a broad range of participants, includ-
ng  patients suffering from pathologies such as autism. It
s  important to note, however, that the signal produced
 the BOLD signal – is not a direct measure of neu-
onal activity, but instead reﬂects the operation of several
ifferent brain processes associated with neuronal activ-
ty,  including synaptic transmitter release, the resulting
elease of signalling molecules that mediate neurovas-
ular coupling and thus increase local blood ﬂow, and
making the BOLD signal smaller) oxygen consumption
Logothetis et al., 2001; Magistretti et al., 1999; Attwell
t  al., 2010).
The  BOLD signal reports changes in the amount of
eoxyhaemoglobin in the blood. Deoxyhaemoglobin is
aramagnetic, and it decreases MRI  signals by makingnitive Neuroscience 6 (2013) 72– 79 73
the  local magnetic ﬁeld less homogenous. During neu-
ronal  activity, the level of deoxyhaemoglobin initially
increases as oxygen use increases, and then decreases as
a  blood ﬂow increase occurs which over-compensates for
the  amount of oxygen used. This decrease in the level of
deoxyhaemoglobin results in a more homogeneous mag-
netic  ﬁeld and thus increases the magnetic resonance
signal. The size of the BOLD signal is larger when there
is  a large blood ﬂow increase, but is decreased by the
use  of oxygen by neurons (for a detailed description, see
Logothetis and Wandell, 2004). In what follows we  focus
simply  on the amplitude of the BOLD signal, because
although BOLD signals are often analysed in terms of
their  stimulus-evoked amplitude relative to the ongoing
noise, a procedure that requires detailed statistical analy-
sis  (Friston, 1995; Friston et al., 2007), even considering
just the amplitude of the signal reveals signiﬁcant con-
cerns  about how to compare control and autistic groups
of  subjects.
When using fMRI to identify differences in neuronal
activity between groups, we  rely upon the assump-
tion that the BOLD signal represents the same set of
processes occurring in these different groups, despite
the neurophysiological differences found in patholo-
gies such as autism. Neurophysiological differences may
include  neuronal activity differences, which is what most
researchers are interested in characterising. However,
they may also include differences in other processes
linked to neuronal activity, such as oxygen consump-
tion or neurovascular coupling. Neurovascular coupling
involves several pathways, both neuronal and glial, that
lead  to the release of vasoactive mediators, such as
nitric oxide, prostaglandins and 20-HETE. These alter
vessel diameter by promoting either smooth muscle relax-
ation,  which increases vessel diameter, or smooth muscle
contraction, which decreases vessel diameter (reviewed
by  Attwell et al., 2010). Changes in how the release
of any of these mediators are controlled by neuronal
activity may  alter the relationship between neuronal
activity and the BOLD signal, potentially obscuring any
differences in neuronal activity between the groups stud-
ied.
In  order to be sure that a BOLD signal difference
between groups reﬂects a neuronal activity difference, it is
important  that we understand as much as possible about
the  factors contributing to the BOLD signal. This means
considering not only the role of neuronal activity, but also
the  involvement of other factors, including neurovascular
coupling and oxygen consumption, which may  differ in
certain  pathologies.
3.  Does neurovascular coupling differ in autism?
As research into the pathology of autism progresses,
we are gaining insight into the neurophysiological abnor-
malities of the autistic brain (reviewed in Belger et al.,
2011), and developing therapeutic strategies to target them
(reviewed in Hampson et al., 2012). It is probable that the
relationship between neuronal activity and blood ﬂow is
affected  by some of these abnormalities, or the medications
used to treat them, as follows (Fig. 1).
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Fig. 1. Pathways from interneurons, neurons and astrocytes that regulate blood ﬂow, leading to either dilation (black arrows to upper half of blood vessel)
or  constriction (black arrows to lower half of blood vessel) of the nearby vasculature. Red arrows indicate how points in these pathways are altered in
autism.  These changes may  affect the relationship between neuronal activity and blood ﬂow response. On the left, excitatory synapses release glutamate
onto  both interneurons and excitatory neurons. In interneurons, activation of glutamate receptors leads to the production of nitric oxide, a diffusible
vasodilatory messenger. It also triggers the release of GABA, which inhibits postsynaptic excitatory neurons, reducing downstream glutamate release. The
action  of glutamate on astrocytic mGluRs leads to the production of both vasoactive dilators and constrictors (note, recent evidence suggests that mGluRs
are  only present on astrocytes during infancy; Sun et al., 2013; see text). Serotonin release provides a basal constriction of blood vessels. (For interpretation
he web of  the references to colour in this ﬁgure legend, the reader is referred to t
4. Abnormalities in neuronal activity
Decreased inhibition is observed in the brains of autis-
tic  patients: the expression of the enzymes that synthesise
the  inhibitory neurotransmitter, GABA, and the expression
of  the receptors on which GABA acts are both reduced
in the autistic brain (Fatemi et al., 2002, 2009, 2010).
This decreased inhibition is a possible therapeutic target
for  treatment of autism, and several drugs that enhance
the action of GABA are currently in phase II clinical tri-
als  (divalproex and arbaclofen; clinicaltrials.gov identiﬁer
NCT00211757 and NCT00846547, respectively). The effect
of  decreased inhibition on neuronal activity can be detected
by  fMRI: because GABA decreases excitability, an autistic
brain  with impaired GABA function would experience more
neuronal  excitability and therefore more neuronal ﬁring
and  more glutamate release, which triggers the release of
vasodilators and increases blood ﬂow (Attwell et al., 2010).
An  increase in BOLD activity would thus be expected, and
in  this case it would be related to changes in neuronal func-
tion.version of the article.)
However,  one major issue with this is the potential
for nonlinearities in the relationships between inhibition,
excitation and blood ﬂow response. For instance, if GABA
activity decreases by half, neuronal excitability will not
necessarily double – simplistically, it could increase by
much  more than a factor of two if the depolarising effect of
reduced  GABA takes most neurons from below to above the
threshold  for action potential ﬁring, or it could increase by
less  than a factor of two if the depolarising effect is not suf-
ﬁcient  to cross this threshold for most neurons. Similarly,
if  neuronal excitability doubles, the blood ﬂow response
will not necessarily double – it could increase by very little
if  blood vessels are already near-maximally dilated, which
may  be the case much of the time in brains where reduced
GABA function increases the level of resting excitability.
A further complication comes from the recent suggestion
that GABA released from interneurons may  act on glial
cells  or directly on microvessels to increase blood ﬂow
(Kocharyn et al., 2008). A reduced action of this pathway
in  autistic patients would lead to a decreased BOLD signal,
unrelated to neuronal excitability.
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How the BOLD signal is affected overall by the change of
ABAergic inhibition in autism will depend, therefore, on
he  relative magnitude of these opposing effects of GABA
n  blood ﬂow, which may  vary between brain regions.
.  Abnormalities in vasoactive mediators
Other neurophysiological changes observed in autism
nclude alterations in the signalling pathways mediating
eurovascular coupling (for a review of neurovascular cou-
ling  pathways, see Attwell et al., 2010). For instance, there
s  a possible role for nitric oxide – a vasodilator released
y neurons in response to activity – in the pathogenesis of
utism.  A study using an animal model of autism, involving
renatal human inﬂuenza viral infection, found region- and
ime-dependent changes in the expression of nNOS, the
euronal  enzyme which produces nitric oxide. Expression
f  nNOS was increased in rostral brain areas at adoles-
ence but eventually down-regulated in adulthood (Fatemi
t  al., 2000). Support for increased NO activity during
evelopment in autism has also been found by assess-
ent of NO production. Expression of adrenomedullin,
hich stimulates NO release, and generation of nitrite, a
etabolic  product of NO, are increased in children with
utism (Zorog˘lu et al., 2003). These ﬁndings suggest that,
uring  development, more nitric oxide will be released in
esponse  to the same amount of activity, which would lead
o  an increased haemodynamic response (and BOLD signal)
n  autistic versus control groups.
The expression of a speciﬁc subtype of metabotropic
lutamate receptor, mGluR5, is also increased in children
 but not adults – with autism (Fatemi et al., 2011; Fatemi
nd Folsom, 2011). Activation of these receptors on astro-
ytes  by glutamate released during synaptic transmission
eads to the production and release of several vasoactive
essengers, which can either increase or decrease blood
ow  (Attwell et al., 2010). Interestingly, recent evidence
uggests that mGluR5 is only present on astrocytes dur-
ng  infancy; in adulthood, mGluR5 expression stays high in
eurons  but is diminished in astrocytes (Sun et al., 2013).
hus,  it is possible that the increased mGluR5 in early
utism is associated with excess expression in astrocytes,
hich would imply an abnormal relationship between
ynaptic activity and haemodynamic response in children
 but not necessarily adults – with autism. Alternatively,
he increased mGluR5 expression in children with autism
ould  have nothing to do with astrocytes – the Western
lot analyses carried out on post-mortem tissue did not
ave  cell-type resolution (Fatemi et al., 2011; Fatemi and
olsom,  2011). Determining whether the upregulation of
GluR5  in children with autism is associated with neu-
onal  or astrocytic expression will be key to categorising
his change as a relevant or confounding factor in the inter-
retation of BOLD signal differences.
Finally, global serotonin synthesis is abnormally low in
hildren  with autism but, in adolescence, it increases grad-
ally  to 1.5 times the level in adult controls (Chugani et al.,
999a).  In children with autism, the action of the presynap-
ic  transporter responsible for active serotonin reuptake
fter synaptic signalling is also reduced (Makkonen et al.,
008).  The authors suggest that this is because fewernitive Neuroscience 6 (2013) 72– 79 75
serotonergic terminals, and therefore transporters them-
selves,  are present in children with autism. If the
reduction in serotonin synthesis and release is matched
or  exceeded by the reduction in serotonin reuptake,
this would be in line with the general view that
the action of serotonin is decreased in early autism.
On the other hand, if the number of transporters is
reduced beyond the reduction in serotonin release,
this would tend to increase the action of synapti-
cally released serotonin. Because serotonin is thought to
produce  a basal constriction of blood vessels (Cohen et al.,
1997),  either a decrease or an increase in serotonergic
activity could change vessel tone, and thus alter the vessel
response to the vasodilators released by a given amount
of  neuronal activity (Blanco et al., 2008). For example, in
low  levels of serotonin, a vessel may  already be close to
its  maximal diameter and thus be less able to dilate in
response to neuronal activity, resulting in a smaller BOLD
response. Conversely, in high levels of serotonin, an highly
constricted vessel could allow a larger dilation in response
to  the same amount of activity, leading to a larger BOLD
response. Alternatively, increased vessel tone could make it
more  difﬁcult for the vessel to dilate (if a larger vasodilatory
signal were needed to overcome the constriction), lead-
ing  to a smaller BOLD response. More research is required
before we  can predict exactly how altered basal tone will
affect  activity-evoked blood ﬂow responses.
6. Abnormalities in energy use
Although some evidence suggests that there is no
change in metabolism (DeVolder et al., 1987; Herold et al.,
1988;  Kaya et al., 2002), several studies ﬁnd metabolic
alterations in autism (Rumsey et al., 1985; Chugani et al.,
1999b;  Weiss et al., 2007, 2008, 2009, 2012). For instance,
Rumsey et al. (1985) used positron emission tomography
to show that glucose utilisation was higher in adult males
with  autism than in controls. In an animal model of autism,
the  Eker rat, basal oxygen consumption was  found to be as
much  as 50% higher than that of control rats (Weiss et al.,
2007).
This  increase in glucose and oxygen use could indi-
cate a greater need for energy in the autistic group. In
line  with this is the suggestion that the increased oxy-
gen  use and cerebral blood ﬂow in Eker rats is due to a
reduced basal activity of GABAA receptors (Weiss et al.,
2008),  which would lead to an overall increase in neuronal
activity, and therefore a greater energy demand. However,
the  increased oxygen use in these rats was  not associated
with an increase in NMDA or AMPA receptor activation
(Weiss et al., 2007, 2009, 2012), suggesting that there may
be  an increase in the activity of non-glutamatergic neurons.
Alternatively, the autistic brain may  require more
metabolic substrate to produce the same amount of energy.
This  is supported by increasing evidence that the func-
tion  of the mitochondrial electron transport chain (ETC) is
impaired  in autism. Compared to controls, a reduction in
the  expression of ETC genes (Anitha et al., 2012) and pro-
teins  (Chauhan et al., 2011) was  seen in the post-mortem
brain tissue of patients with autism. Thus, oxidative phos-
phorylation may  not be as effective in the autistic brain,
ntal Cog76 C. Reynell, J.J. Harris / Developme
perhaps requiring more oxygen and/or glucose to pro-
duce  the same amount of ATP. Since the amount of energy
needed to restore ionic concentrations after neuronal
signalling is ﬁxed by the amount of sodium ion entry occur-
ring  (Attwell and Laughlin, 2001), this would imply a larger
oxygen  requirement to support the same level of neuronal
activity. If this excess oxygen were obtained by increased
oxygen extraction from the blood, then this would lead to
a  smaller BOLD response. However, in the mouse model
of  autism, oxygen extraction is unchanged while cerebral
blood ﬂow is increased (Weiss et al., 2007, 2008, 2012),
suggesting that the excess oxygen is obtained by increased
vascular supply. This would lead to a larger BOLD response
to  the same amount of neuronal activity in people with
autism.
7.  Medication-related effects on neurovascular
coupling
The medication used to treat autism may  also affect
the relationship between neuronal activity and the BOLD
response. For example, serotonin reuptake inhibitors
(SSRIs), a medication commonly used by autistic patients,
increase extracellular serotonin levels in the brain. They
may,  therefore, increase the tone of vessels – perhaps
beyond normal levels – and thus alter the blood ﬂow
response evoked by neuronal activity (see above). A recent
study  by Feczko et al. (2012) addressed this question, ﬁnd-
ing  no signiﬁcant difference in the BOLD response to a
visuomotor task presented to non-medicated participants
and those taking SSRIs, in the brain areas they examined.
However, this does not rule out SSRI-induced neurovascu-
lar  coupling changes in the brain circuits that underpin the
social  behaviours more closely associated with the autistic
phenotype.
8.  Potential impact of neurovascular coupling
changes in autism on fMRI studies
Having highlighted some of the neurophysiological dif-
ferences  found in autism that may  alter the relationship
between neuronal activity and the BOLD response in this
condition, we will now consider some fMRI studies in
which  the results may  be affected by these differences.
Goldberg et al. (2011) asked children with or without
high functioning autism spectrum disorder (ASD) to carry
out  an error monitoring task. After a trial in which an error
was  made, the BOLD signal in the anterior medial pre-
frontal cortex and the superior temporal gyrus was found
to  increase in ASD participants compared to control partic-
ipants.  This increase in the BOLD signal was interpreted
as increased neuronal activity in these regions. Because
the  behavioural performance on the task was the same
for  both groups, the assumed increase in neuronal activ-
ity  was suggested to indicate a “greater attention towards
the  internally-driven emotional state associated with mak-
ing  an error” in children with ASD. But the authors did
not  take any steps to rule out the possibility that the
difference between these groups may  be neurovascular
in nature, and nothing to do with neuronal activity. For
instance, the increased nitric oxide level found in childrennitive Neuroscience 6 (2013) 72– 79
with  autism (Zorog˘lu et al., 2003) could lead to a larger
vascular response to activation of the same number of neu-
rons  (see above). This would cause the BOLD response to
appear  larger in children with autism, despite no difference
in  neuronal activity.
Watanabe  et al. (2012) found that the BOLD response to
a  social judgement task was decreased in participants with
ASD  compared to control participants. The degree of BOLD
signal  reduction in the two regions most active in control
participants during this task (the anterior cingulate cor-
tex/ventromedial prefrontal cortex and the dorsal medial
prefrontal cortex) predicted the severity of communica-
tion deﬁcit in the ASD group. This result might suggest that
some  physiological abnormality in these regions is associ-
ated  with the behavioural abnormality in social judgement.
However, the idea that the physiological abnormality is
reduced  neuronal activity can only be an assumption until
other  possibilities are ruled out. For example, the decreased
serotonin levels seen in autistic patients (Chugani et al.,
1999a)  may  restrict the amplitude of the vascular and thus
the  BOLD response (see above). The authors point out that
the  reduction in the BOLD response in autistic partici-
pants is not global, as task-evoked activity in one area, the
amygdala, was  found to increase. However, neurovascu-
lar coupling mechanisms can be pathway-speciﬁc (Enager
et  al., 2009) and, therefore, task-speciﬁc. It is thus possible
that  changes in neurovascular coupling are responsible for
either  the decreased or increased BOLD responses found by
Watanabe  et al. (2012).
Pfeifer  et al. (2012) compared the BOLD signal when
participants were asked to make an appraisal of them-
selves or of others. In typically developing children and
adolescents, two main brain regions – the medial prefrontal
cortex (mPFC) and the middle cingulate cortex (MCC) –
showed  an increased BOLD response during self-appraisal
compared to appraisal of others. Age-matched participants
with ASD lacked any task-related pattern in the mPFC, and
showed  the opposite pattern in the MCC  (increased BOLD
signal  when appraising others compared to self). However,
with  increasing age in the ASD group, the BOLD signal in the
mPFC  associated with the differentiation of the self from
others  was  found to increase. This trend suggests that this
brain  region is increasingly relied upon as the social impor-
tance  of the self-other distinction is learned. However, the
interpretation of age-related BOLD changes comes with its
own  set of issues, as the neurovasculature matures (Harris
et  al., 2011), perhaps differently in autistic and typically
developing populations.
9.  Experimentally excluding neurovascular
coupling differences
Since  most researchers are interested in the neuronal
changes associated with autism, most changes in fMRI
response are simply assumed to be due to altered neuronal
processing rather than altered neurovascular coupling or
oxygen  use. None of the studies above considered neu-
rovascular abnormalities in autism, which, if present could
directly  affect the BOLD signal even in the absence of
changes in neuronal activity. The mislabelling of neu-
rovascular changes as neuronal activity changes could
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e misleading. The best way to avoid this is with an
xperimental design that can distinguish a neurovascular
oupling (or oxygen use) change from a neuronal activity
hange. A few labs have begun to design experiments with
his  goal in mind.
Feczko  et al. (2012) asked children with and without
SD to press a button at the onset and offset of a visually
resented ﬂickering chequerboard, and compared BOLD
esponses in the two groups during this task in 19 differ-
nt  brain regions. The same paradigm has previously been
mployed to compare BOLD responses across age groups
Kang  et al., 2003). This approach assumes that the neu-
onal  activity mediating a simple, low-level task is not
ffected by autism (or age). This assumption may  not be
alid,  since altered visual processing has been reported in
he  retina and striate cortex in autism (Ritvo et al., 1988;
immons et al., 2009; Neumann et al., 2011; but see Koh
t  al., 2010). But if it is a correct assumption, then identi-
al  BOLD responses in the two groups would presumably
mply that neurovascular coupling is the same in the two
roups.
Since  Feczko et al. found no signiﬁcant difference in
he  visual task-evoked BOLD response between ASD and
ontrol  children, they argued that neurovascular coupling
n  the two groups must be the same, ideally throughout
he brain. This is the most parsimonious argument, but
he  authors do acknowledge the small possibility that a
onfounding difference in neurovascular coupling that has
qual  and opposite effects to a difference in neuronal activ-
ty  between the groups could lead to the same overall BOLD
ignal.  For example, a smaller amount of neuronal activity
n  autism may  be compensated for by a stronger neurovas-
ular signalling pathway, or vice versa. In this case, a similar
lood  ﬂow response would be produced in the different
roups by differing levels of neuronal activity.
Even if one accepts the argument that a similar BOLD
esponse for a low level visual task implies similar neu-
ovascular coupling, as noted by the authors, it can only be
ade  for this particular visual task and need not generalise
o  other tasks. As mentioned above, this is because differ-
nt  tasks activate different brain regions, different neuronal
athways and different neurotransmitter systems, which
ary  in their neurovascular coupling mechanisms (Sloan
t  al., 2010; Devonshire et al., 2012). Indeed, even within
he  same brain region, neuronal activity evoked by differ-
nt  inputs can generate different BOLD responses (Enager
t  al., 2009).
Such  input- or task-speciﬁc neurovascular coupling
akes it difﬁcult for results based on one task alone to
e  extrapolated usefully to general claims about neurovas-
ular coupling between groups – it is always a possibility
hat the chosen task happens to be one in which neu-
onal responses and neurovascular coupling are not altered
etween groups, while for tasks employing different brain
egions  and pathways there may  indeed be differences of
eurovascular coupling between the groups. For example,
n  Feczko et al.’s case, it is possible that low level visual
reas do not have their neurovascular coupling altered
y  the neuronal changes associated with autism, while
rain  areas dealing with social interactions do have their
eurovascular coupling altered. Nevertheless, this studynitive Neuroscience 6 (2013) 72– 79 77
represents the ﬁrst attempt to experimentally rule out neu-
rovascular coupling confounds in the interpretation of fMRI
data,  and paves the way for paradigms which address this
issue  directly.
Dinstein et al. (2012) used a different approach
to exclude the possibility that an increase in the
variability of neurovascular coupling in autism might
underpin the greater fMRI response variability that they
observed. Speciﬁcally, they found that, although mean
evoked responses to several stimuli (visual, auditory, and
somatosensory) did not differ between participants with
and  without autism, there was  a signiﬁcant increase in
trial-by-trial variability in participants with autism. They
compared these task-evoked responses in visual, auditory
or  somatosensory regions (“local evoked activity”) with the
fMRI  ﬂuctuations that were common to the entire cortex in
the  absence of stimulus-evoked responses (“global ongoing
activity”), which did not show increased variability in par-
ticipants  with autism. Because the authors started with the
assumption that a change in neurovascular coupling would
affect  “evoked responses and ongoing activity in a similar
manner”, they argued that neurovascular coupling changes
could  therefore not be the source of the increased variabil-
ity  in the local task-evoked BOLD signals. The conclusion
followed that task-related neuronal activity is abnormally
unreliable in autism.
This  line of reasoning on its own is weak, because there
is  no reason why a neurovascular coupling change could
not  selectively alter task-evoked signalling to the vascul-
ature without affecting resting state blood ﬂow. This is
obvious  when one considers that the majority of neu-
rovascular coupling changes are likely to occur at points
along the pathway from synaptic transmission to vessel
dilation/constriction, and may  therefore only be revealed
during task-evoked synaptic activity.
Nevertheless, Dinstein et al.’s conclusions are supported
by EEG data showing that visual task-evoked response
variability is signiﬁcantly greater in participants with ASD
(Milne,  2011). The combination of fMRI with a direct mea-
sure  of neuronal activity, such as EEG, is one of the most
hopeful approaches for experimentally dissecting out the
relative  contributions of altered neuronal activity and neu-
rovascular  coupling to differences in the BOLD signal.
For instance, an increased BOLD response echoed by an
increased EEG response to the same task is a very good indi-
cation  that the BOLD increase reﬂects increased neuronal
activity. The fMRI data can then be used to gain a clearer
spatial picture of the change. If, however, BOLD and EEG
data  contradict one another, this would indicate that other
factors  – perhaps a change in neurovascular coupling or
energy  use – are contributing to the BOLD signal difference.
In  this way, performing EEG alongside fMRI can guide the
identiﬁcation of the neuronal differences between groups.
10.  Conclusion
Autism is a brain disorder, with its diverse behavioural
phenotypes rooted in abnormalities of neuronal circuitry
and  function, and we  do not wish to suggest that fMRI
cannot reveal these neuronal differences. The aim of this
review  is to dispel the idea that neurovascular coupling
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can be lumped in with easily corrected for non-neuronal
confounds such as head motion or breathing artefacts. On
the  contrary, neurovascular coupling changes can have pro-
found,  complex and region- and task-speciﬁc effects on
cerebral  blood ﬂow and therefore the BOLD signal.
Autism is associated with many neurophysiological
changes, and there are just as many reasons why  an abnor-
mal  relationship between neuronal activity and the BOLD
signal  might therefore be expected. Being aware of these
potential neurovascular coupling and energy use differ-
ences  will be critical to the ﬁeld’s ability to dissect out
the  neuronal changes that underpin behavioural differ-
ences. Eventually, detailed knowledge of the physiology
of  the BOLD signal (Attwell and Iadecola, 2002) will allow
more  conﬁdent interpretation of BOLD response differ-
ences  between participants. The most promising way to
achieve  this is by using a combination of imaging and physi-
ological  research in animals (Devonshire et al., 2012; Schulz
et  al., 2012). Meanwhile, an experimental approach – based
around  carefully chosen control tasks or a combination of
fMRI  and EEG (or, indeed, any method that reports the
electrical activity of neurons, such as MEG) – is the best
strategy to distinguish the contributions of neurovascular
coupling and of neuronal activity to differences in BOLD
signals  between groups.
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